Targeted and Immune-Based Therapies for Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Targeted and Immune-Based Therapies for Hepatocellular Carcinoma

Published:2019-01 Issue:2 Volume:156 Page:510-524
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Greten Tim F.,Lai Chunwei Walter,Li Guangfu^ORCID,Staveley-O’Carroll Kevin F.

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference125 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report;Clavien;Lancet Oncol,2012

3. Personalized treatment of patients with very early hepatocellular carcinoma;Vitale;J Hepatol,2017

4. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma;J Hepatol,2018

5. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach;Hepatology,2018

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular carcinoma;Treatment and Management of Tropical Liver Disease;2025

2. Recent advancements in the small-molecule drugs for hepatocellular carcinoma (HCC): Structure-activity relationships, pharmacological activities, and the clinical trials;Biomedicine & Pharmacotherapy;2024-10

3. Protein tyrosine phosphatase non-receptor II: A possible biomarker of poor prognosis and mediator of immune evasion in hepatocellular carcinoma;World Journal of Gastrointestinal Oncology;2024-09-15

4. Exploration of Key Genes Combining with Immune Infiltration Level and Tumor Mutational Burden in Hepatocellular Carcinoma;Combinatorial Chemistry & High Throughput Screening;2024-09

5. Combination Therapy Consisting of Transarterial Chemoembolization, Lenvatinib, and Programmed Cell Death Protein 1 Blockade for Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus: A Case Series Study and Literature Review;Oncology Research and Treatment;2024-08-07